- Nachrichtendetail
-
11.06.2024 13:04:01 - dpa-AFX: *REGENERON AND SANOFI: FDA APPROVES KEVZARA FOR TREATMENT OF ACTIVE POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
SANOFI SA INHABER EO 2 | 920657 | Xetra | 103,520 | 24.09.24 17:35:52 | -0,220 | -0,21% | 0,000 | 0,000 | 103,580 | 103,740 |
|
Regeneron Pharmaceuticals | 881535 | NASDAQ | 1.025,495 | 24.09.24 20:09:08 | -66,485 | -6,09% | 1.025,020 | 1.025,970 | 1.076,330 | 1.091,980 |
